Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies | BMC Medicine User montaukwhaler, in the non small cell lung cancer subreddit, 02 May 2023